openPR Logo
Press release

Global Trigeminal Neuralgia Treatment Medicine Market Comprehensive Insight by Growth Rate, Industry Status, Forecast till 2028

05-27-2022 01:47 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Orion Market Research

The trigeminal neuralgia treatment medicine market is anticipated to grow at a significant CAGR of 6.0%  during the forecast period (2022-2028). Trigeminal neuralgia is a condition in which on one side of the face, pain sensations similar to an electric shock are experienced. This is a chronic condition that appears from time to time.  The trigeminal nerve is affected in this condition and pain sensations travel from the face to the brain. In the case of trigeminal neuralgia, minimal movement or touching of the face parts such as brushing teeth or doing makeup can trigger unbearable pain shock on the face. In conditions, initially, there are mild attacks but after some time, the time and frequency of the pain shock increase.  trigeminal neuralgia is mostly seen in the geriatric population. This condition can be effectively managed by medications and surgery. As per National Center for Biotechnology Information in the United States, the prevalence rate of trigeminal neuralgia is 4 to 13 per 100000 people.
 
 
The global trigeminal neuralgia treatment medicine market is segmented by type and by end-user. Based on type, the market is sub-segmented into anticonvulsants, antispasmodic agents, and botox injections. Based on end-user, the market is sub-segmented into hospitals, clinics, and others. Anticonvulsants such as carbamazepine (Tegretol, Carbatrol, others) are prescribed by health experts in the treatment of trigeminal neuralgia and these have proved effective in treating chronic pain which lasts longer than a month. Some other anticonvulsants which are prescribed in trigeminal neuralgia are oxcarbazepine (Trileptal, Oxtellar XR).
 
 
Some major players in the market include Novartis AG, Allergen Plc, GlaxoSmithKline Plc, Abbott Laboratories. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in Feb 2022, Noema Pharma has announced that it has started the clinical trial of  mGluR5 inhibitor NOE-101. This drug would be used to treat trigeminal neuralgia. According to the company it has tested this drug on the first patient enrolled for this trial. NOE-101 is an allosteric modulator of mGlu5 and is highly selective and potent. The clinical trial which is associated with this drug is named as Phase IIb LibraTN study.
 

(Get 15% Discount on Buying this Report)
Get Sample Copy of Global Trigeminal Neuralgia Treatment Medicine Market at https://orionmarketreports.com/request-sample/?id=109759&submit=Request+Sample%0D%0A
Market Coverage
The market number available for - 2021-2028
Base year- 2021
Forecast period- 2022-2028
Segment Covered-
By Type
By End-User
Regions Covered-
North America
Europe
Asia-Pacific
Rest of the World
Competitive Landscape- Novartis AG, Allergen Plc, GlaxoSmithKline Plc,Abbott Laboratories.

A full report is available at: https://orionmarketreports.com/global-trigeminal-neuralgia-treatment-medicine-market/109759/

Trigeminal Neuralgia Treatment Medicine Market Report By Segment
By Type
Anticonvulsants
Antispasmodic Agents
Botox Injections
By End-User
Hospital
Clinic
Others

Key questions addressed by the report
What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How has COVID-19 impacted the market?
Deviation from the pre-COVID-19 forecast
Most affected region and segment
Who is the leader in the market?
How players are addressing challenges to sustain growth?
Where is the investment opportunity?

Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404

About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Trigeminal Neuralgia Treatment Medicine Market Comprehensive Insight by Growth Rate, Industry Status, Forecast till 2028 here

News-ID: 2639193 • Views:

More Releases from Orion Market Research

AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2033
AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2 …
AI-enabled imaging modalities market was valued at approximately USD 1.36 billion, and it is projected to reach around USD 19.78 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 34.67% from 2024 to 2033. AI-Enabled Imaging Modalities Market Overview The AI-enabled imaging modalities market is experiencing rapid growth, driven by advancements in artificial intelligence and machine learning technologies. These innovations are enhancing the capabilities of various imaging modalities, including
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Playe …
Global tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033. Tumor Tracking Systems Market Overview The tumor tracking systems market is experiencing steady growth, driven by the increasing incidence of cancer and advancements in imaging and tracking technologies. These systems improve the precision of
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry Growths to 2033
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry …
Tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033. Tumor Tracking Systems Market Overview The tumor tracking systems market is experiencing steady growth, driven by the increasing prevalence of cancer and advancements in imaging technologies. These systems play a crucial role in enhancing the
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and G …
SNP genotyping market was valued at approximately USD 31.66 billion, and it is projected to reach around USD 238.25 billion by 2034, reflecting a compound annual growth rate (CAGR) of about 20.1% from 2024 to 2034. SNP genotyping Market Overview The SNP genotyping market is experiencing significant growth, driven by advancements in genotyping technologies, an increase in the prevalence of genetic disorders, and the expansion of pharmacogenomics and precision medicine initiatives. This

All 5 Releases


More Releases for Plc

Online Gambling and Betting Global Market 2020 | Major Kay Players – NetEnt AB …
WiseGuyRerports.com Presents “Global Online Gambling and Betting Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025” New Document to its Studies Database The Online Gambling and Betting report provides an estimated valuation and analysis on a regional as well as a global level. A detailed research on the performance of the various market dynamics and its impact on the overall landscape in the present and future are explored in
Online Gambling and Betting Market Size, Share and Revenue Analysis by NetEnt AB …
Global Online Gambling and Betting Market Size, Status and Forecast 2018-2025 Report presents the worldwide Online Gambling and Betting Market analysis with in depth study of manufacturers, region, type and application and its future scope in the industry till 2025. Gambling is the wagering of money or something of value (referred to as “the stakes”) on an event with an uncertain outcome with the primary intent of winning money or material
Online Gambling Market Trends, Insights, Technology till 2025 NetEnt AB, GVC Hol …
Global Online Gambling Market Size, Status and Forecast 2018-2025 Report presents the worldwide Online Gambling Market analysis with in depth study of manufacturers, region, type and application and its future scope in the industry till 2025. This report focuses on the global Online Gambling status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Online Gambling development in United States, Europe and China. In
Online Gambling and Betting Market Outlook to 2023 – NetEnt AB, GVC Holdings P …
Oct 2018, New York, USA(News)- Online gambling (or Internet gambling) includes poker, casinos and sports betting. The first online casino was in 1994. Many countries restrict or ban online gambling, but it is legal in some provinces in Canada, most countries of the European Union and several nations in the Caribbean. In 1994, Antigua and Barbuda passed the Free Trade & Processing Act, allowing licences to be granted to organisations
Pulmonary Drugs Market Continues Growth | 2018 Key Players are Meda Pharmaceutic …
The major manufacturers are focused towards development of new and innovative products with extensive R&D on pulmonary drugs. For instance, in 2017, Sanofi SA completed the phase II clinical trials in April 2017 of new drug Dupilumab in association with Regeneron Pharmaceuticals. The drug is indicated for the treatment of uncontrolled asthma in children and is expected to complete its clinical trial studies in January, 2021. Moreover, in 2017, Circassia
Online Gambling Global Market 2018: Key Players – William Hill Plc., Paddy Pow …
Online Gambling Industry Description Wiseguyreports.Com Adds “Online Gambling -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023” To Its Research Database Online Gambling refers to betting of money online on an event with an uncertain outcome. Online gambling is similar to gambling but the difference is that online gambling is betting on sports or casino over the internet. Online gambling is not limited to playing cards. It is a